Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Mar 14, 2018)
  • 8-K (Jan 29, 2018)
  • 8-K (Jan 4, 2018)
  • 8-K (Nov 9, 2017)
  • 8-K (Sep 22, 2017)
  • 8-K (Aug 8, 2017)

 
Other

CAS Medical Systems 8-K 2015

Documents found in this filing:

  1. 8-K
  2. 8-K
form8-k_17740.htm


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549


FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):    January 5, 2015
 

 
CAS MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)


Delaware
(State or other jurisdiction
of incorporation)
0-13839
(Commission
File Number)
06-1123096
(I.R.S. Employer
Identification No.)
 
44 East Industrial Road, Branford, Connecticut 06405
(Address of principal executive offices, including zip code)
 
(203) 488-6056
(Registrant's telephone number, including area code)
 
 
 

 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 
 
 
 
 
 
Item 5.02
DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
 
Effective January 5, 2015, the Board of Directors of CAS Medical Systems, Inc. (the “Company”) appointed Paul A. Molloy to fill the vacancy on the Board resulting from the departure of Lawrence S. Burstein.  The Board of Directors has not yet determined Mr. Molloy’s Board committee assignments.

Since 2013 Mr. Molloy has been the CEO of ClearFlow Inc., an early-stage medical device company focused on post-surgical wound management.  From 2010 to 2013, he was President of the Vascular Division of Teleflex Inc. and CEO of VasoNova, Inc. prior to its acquisition by Teleflex.  From 2008 to 2010, Mr. Molloy was President and CEO of MiCardia Corp.  Mr. Molloy has over 20 years of management experience in the medical device industry and also serves on the Board of Directors of privately-held ClearFlow Inc. and Velano Vascular, Inc.  He is a graduate of the Instituut der Bedrijfswetenschappen, Utrecht, Netherlands, and has an M.B.A. from the University of Chicago Booth School of Business.

The Company issued a press release with respect to the foregoing appointment, which is attached hereto as Exhibit 99.1.
 
 
 
 
 
 
Item 9.01
FINANCIAL STATEMENTS AND EXHIBITS
 
(d)           Exhibits – The following exhibit is filed as part of this report:

99.1
Press Release dated January 5, 2015

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- 2 -

 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
  CAS MEDICAL SYSTEMS, INC.  
       
       
       
Date:   January 8, 2015
By:     /s/ Jeffery A. Baird  
   
Jeffery A. Baird
 
   
Chief Financial Officer
 
       

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
- 3 -

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki